HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.
作者： Thomas A Thomson , Malcolm M Hayes , John J Spinelli , Ernie Hilland , Christina Sawrenko
DOI: 10.1038/MODPATHOL.3880440
关键词:
摘要: HER-2/ neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared Fluorescent In Situ Hybridization
nature.com
sci-hub.se 参考文章(19)
J A Fletcher, J S Ross, HER-2/neu (c-erb-B2) gene and protein in breast cancer. American Journal of Clinical Pathology. ,vol. 112, ,(1999)
Godolphin W, Pauletti G, Press Mf, Slamon Dj, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. ,vol. 13, pp. 63- 72 ,(1996)
M F Press, L Bernstein, P A Thomas, L F Meisner, J Y Zhou, Y Ma, G Hung, R A Robinson, C Harris, A El-Naggar, D J Slamon, R N Phillips, J S Ross, S R Wolman, K J Flom, HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Journal of Clinical Oncology. ,vol. 15, pp. 2894- 2904 ,(1997) , 10.1200/JCO.1997.15.8.2894
Ann D. Thor, Donald A. Berry, Daniel R. Budman, Hyman B. Muss, Timothy Kute, I. Craig Henderson, Maurice Barcos, Constance Cirrincione, Susan Edgerton, Craig Allred, Larry Norton, Edison T. Liu, erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer Journal of the National Cancer Institute. ,vol. 90, pp. 1346- 1360 ,(1998) , 10.1093/JNCI/90.18.1346
Jérôme Couturier, Anne Vincent-Salomon, André Nicolas, Philippe Beuzeboc, Emmanuelle Mouret, Brigitte Zafrani, Xavier Sastre-Garau, Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/ neu ) Gene Status in Breast Carcinoma Modern Pathology. ,vol. 13, pp. 1238- 1243 ,(2000) , 10.1038/MODPATHOL.3880228
E W Kay, C J Walsh, M Cassidy, B Curran, M Leader, C-erbB-2 immunostaining: problems with interpretation. Journal of Clinical Pathology. ,vol. 47, pp. 816- 822 ,(1994) , 10.1136/JCP.47.9.816
Frédérique Penault-Llorca, José Adelaïde, Gilles Houvenaeghel, Jacques Hassoun, Daniel Birnbaum, Jocelyne Jacquemier, Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixation The Journal of Pathology. ,vol. 173, pp. 65- 75 ,(1994) , 10.1002/PATH.1711730111
Rafael E Jimenez, Tracy Wallis, Pam Tabasczka, Daniel W Visscher, Determination of Her-2/ Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ Hybridization Modern Pathology. ,vol. 13, pp. 37- 45 ,(2000) , 10.1038/MODPATHOL.3880007
D. Slamon, W Godolphin, L. Jones, J. Holt, S. Wong, D. Keith, W. Levin, S. Stuart, J Udove, A Ullrich, al. et, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. ,vol. 244, pp. 707- 712 ,(1989) , 10.1126/SCIENCE.2470152
Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji, Melissa J. Barnes, Stuart J. Schnitt, Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System Journal of Clinical Oncology. ,vol. 17, pp. 1983- 1983 ,(1999) , 10.1200/JCO.1999.17.7.1983